C Briguori

Summary

Affiliation: San Raffaele Scientific Institute
Country: Italy

Publications

  1. ncbi Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio 2, I 80121 Naples, Italy
    Eur Heart J 25:1822-8. 2004
  2. ncbi Endovascular repair of a carotid pseudoaneurysm with Fluency Plus stent graft implantation
    Carlo Briguori
    Laboratory of Interventional Cardiology and the Department of Cardiology, Clinica Mediterranea, Naples, Italy
    J Invasive Cardiol 19:E254-7. 2007
  3. ncbi Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, University of Milan, Milan, Italy
    Eur Heart J 25:206-11. 2004
  4. ncbi Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies
    Carlo Briguori
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Via Orazio, 2, I 80121, Naples, Italy
    Circulation 115:1211-7. 2007
  5. ncbi Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Am J Cardiol 97:472-6. 2006
  6. ncbi Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Kidney Int 68:2250-5. 2005
  7. ncbi Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus
    Carlo Briguori
    Interventional Cardiology, Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Am J Cardiol 99:779-84. 2007
  8. ncbi N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    J Am Coll Cardiol 44:762-5. 2004
  9. ncbi New pharmacological protocols to prevent or reduce contrast media nephropathy
    C Briguori
    Laboratory of Interventional Cardiology, Mediterranean Clinic, Naples, Italy
    Minerva Cardioangiol 53:49-58. 2005
  10. pmc Clinical and angiographic outcome of directional atherectomy followed by stent implantation in de novo lesions located at the ostium of the left anterior descending coronary artery
    F Airoldi
    EMO Centro Cuore, Columbus Clinic and Interventional Cardiology Unit, San Raffaele Hospital IRCCS, Milan, Italy
    Heart 89:1050-4. 2003

Detail Information

Publications68

  1. ncbi Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio 2, I 80121 Naples, Italy
    Eur Heart J 25:1822-8. 2004
    ..Peri-procedural non-Q-wave myocardial infarction is a frequent and prognostically important complication of percutaneous coronary intervention (PCI). It has been postulated that statins may reduce the rate of myocardial injury after PCI...
  2. ncbi Endovascular repair of a carotid pseudoaneurysm with Fluency Plus stent graft implantation
    Carlo Briguori
    Laboratory of Interventional Cardiology and the Department of Cardiology, Clinica Mediterranea, Naples, Italy
    J Invasive Cardiol 19:E254-7. 2007
    ....
  3. ncbi Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, University of Milan, Milan, Italy
    Eur Heart J 25:206-11. 2004
    ..We tested whether a double dose of NAC is more effective to prevent CAN...
  4. ncbi Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies
    Carlo Briguori
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Via Orazio, 2, I 80121, Naples, Italy
    Circulation 115:1211-7. 2007
    ..Preliminary data support the concept that sodium bicarbonate and ascorbic acid also may be effective in preventing CIN...
  5. ncbi Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Am J Cardiol 97:472-6. 2006
    ..In conclusion, plasma levels of angiogenic growth factors differ among patients with stable angina pectoris and longstanding total coronary occlusion...
  6. ncbi Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Kidney Int 68:2250-5. 2005
    ..We evaluated the nephrotoxicity of iso- and low-osmolality contrast agents with prophylactic administration of N-acetylcysteine (NAC) along with hydration...
  7. ncbi Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus
    Carlo Briguori
    Interventional Cardiology, Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Am J Cardiol 99:779-84. 2007
    ..No difference seems to exist in the rate of death, stroke, and myocardial infarction...
  8. ncbi N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    J Am Coll Cardiol 44:762-5. 2004
    ..We performed a study to assess the efficacy of fenoldopam mesylate (a specific agonist of the dopamine-1 receptor) as compared with N-acetylcysteine (NAC) in preventing contrast agent-associated nephrotoxicity (CAN)...
  9. ncbi New pharmacological protocols to prevent or reduce contrast media nephropathy
    C Briguori
    Laboratory of Interventional Cardiology, Mediterranean Clinic, Naples, Italy
    Minerva Cardioangiol 53:49-58. 2005
    ..Recently, considerable interest has resulted from the preliminary positive data on the effectiveness of prophylactic administration of antioxidant compounds (such as acetylcysteine and ascorbic acid) and fenoldopam...
  10. pmc Clinical and angiographic outcome of directional atherectomy followed by stent implantation in de novo lesions located at the ostium of the left anterior descending coronary artery
    F Airoldi
    EMO Centro Cuore, Columbus Clinic and Interventional Cardiology Unit, San Raffaele Hospital IRCCS, Milan, Italy
    Heart 89:1050-4. 2003
    ....
  11. ncbi Assessment of the functional significance of coronary lesions using a monorail catheter
    C Briguori
    Centro Cuore Columbus, Via M Buonarroti, 48, I 20145, Milan, Italy
    J Invasive Cardiol 13:279-86. 2001
    ..65, FFRPW is always > 0.75. These data demonstrate that even with larger cross-sectional area than a pressure wire, the MFP catheter can easily and reliably be used to assess the functional severity of coronary stenosis...
  12. ncbi Predictors of re-occlusion after successful recanalization of chronic total occlusion
    M Sallam
    Department of Interventional Cardiology, San Raffaele Hospital, Via Olgettina, 60, 20132, Milan, Italy
    J Invasive Cardiol 13:511-5. 2001
    ..46, 95% CI = 1.12-1.82; p = 0.0069). CONCLUSION: Re-occlusion occurs in about 11% of cases after stenting chronic total occlusion. The most important predictor of re-occlusion seems to be stent length...
  13. ncbi Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve
    C Briguori
    EMO Centro Cuore Columbus, and San Raffaele Hospital, Milan, Italy
    Am J Cardiol 87:136-41. 2001
    ..In 53 intermediate coronary lesions found by angiography, IVUS area stenosis >70%, MLD < or =1.8 mm, MLA < or =4.0 mm2, and lesion length > 10 mm reliably identified functionally critical intermediate coronary stenoses...
  14. ncbi Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings
    A Anzuini
    Vita e Salute University, San Raffaele Hospital, Milan, Italy
    Am J Cardiol 88:1246-50. 2001
    ..In contrast, a complex approach does not appear to give any benefit in terms of early or long-term outcome or restenosis rate...
  15. ncbi Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results
    Dejan Orlic
    EMO, Centro Cuore Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:1154-60. 2004
    ..This study evaluated clinical outcome after multivessel stenting with sirolimus-eluting stents (SES) in unselected lesions...
  16. ncbi Characterization of total occlusions with intracoronary ultrasound: the importance of the duration of occlusion
    T Nishida
    EMO Centro Cuore Columbus, Columbus Clinic and Catheterization Laboratory, San Raffaele Hospital, Via Buonarroti 48, 20145, Milan, Italy
    J Invasive Cardiol 13:1-8. 2001
    ..040), and with a smaller angiographic proximal reference diameter (p = 0.043). CONCLUSION: Long-standing occlusions undergo lesion shrinkage and exhibit more extensive calcification...
  17. ncbi Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation
    Giuseppe Tarantini
    EMO Centro Cuore Columbus, San Raffaele Hospital, Milan, Italy
    Ital Heart J 4:843-9. 2003
    ..The predictors of outcome in such patients after coronary stenting have not been clarified...
  18. ncbi Emergency stenting to treat neurological complications occurring after carotid endarterectomy
    A Anzuini
    Department of Cardiology, IRCCS San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 37:2074-9. 2001
    ..024). CONCLUSIONS: Stent implantation seems to be a safe and effective strategy in the treatment of perioperative stroke complicating CEA, especially when carotid dissection represents the main anatomic problem...
  19. ncbi Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era
    Giuseppe G L Biondi-Zoccai
    St Raffaele Hospital, Milan, Italy
    Am J Cardiol 95:1466-8. 2005
    ..Such results may provide useful information to guide prevention of this complication...
  20. doi Cystatin C and contrast-induced acute kidney injury
    Carlo Briguori
    Interventional Cardiology, Clinica Mediterranea, Via Orazio, 2, I 80121, Naples, Italy
    Circulation 121:2117-22. 2010
    ..Cystatin C (CyC) is more sensitive than serum creatinine (sCr) to rapidly detect acute changes in renal function...
  21. ncbi Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Catheter Cardiovasc Interv 67:175-80. 2006
    ..We tested whether gadolinium-based contrast agent is less nephrotoxic than iodinated-contrast media...
  22. ncbi Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery
    Takuro Takagi
    EMO Centro Cuore Columbus, Milan, Italy
    Circulation 106:698-702. 2002
    ..The safety and efficacy of percutaneous coronary intervention of de novo lesions in unprotected left main coronary arteries remains an unresolved issue...
  23. ncbi Acetylcysteine and contrast agent-associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio 2, I 80121 Naples, Italy
    J Am Coll Cardiol 40:298-303. 2002
    ..Prophylactic acetylcysteine along with hydration seems to be better than hydration alone in preventing the reduction in renal function induced by a contrast dye...
  24. ncbi In-stent restenosis in small coronary arteries: impact of strut thickness
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 40:403-9. 2002
    ..OBJECTIVES; We sought to evaluate whether strut thickness may impact the restenosis rate after stent implantation in small coronary arteries...
  25. ncbi Discrepancy between angiography and intravascular ultrasound when analysing small coronary arteries
    C Briguori
    San Raffaele Hospital, Milan, Italy
    Eur Heart J 23:247-54. 2002
    ..We endeavoured to confirm the difference between data from examinations conducted using angiography with that revealed by intravascular ultrasound...
  26. ncbi Endovascular stenting for the nutcracker phenomenon
    R Chiesa
    Department of Vascular Surgery, Vita e Salute University, San Raffaele Hospital, Milan, Italy
    J Endovasc Ther 8:652-5. 2001
    ..To present a case highlighting the efficacy of stent implantation for left renal vein (LRV) entrapment, otherwise known as the nutcracker phenomenon...
  27. ncbi 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease
    Flavio Airoldi
    Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:664-7. 2005
    ..47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-beta-E eluting stent over the control PC stent...
  28. ncbi Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside
    Flavio Airoldi
    San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 99:916-20. 2007
    ..In conclusion, the standardized protocol of intracoronary NTP administration succeeded in normalizing SCF in all patients with AMI but in only 5 of 9 patients with SVG stenosis. This latter subgroup requires other therapeutic strategies...
  29. ncbi Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease
    Carlo Briguori
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy
    Am Heart J 150:807-13. 2005
    ..We evaluated the impact of SES implantation on immediate and 12-month outcome in diabetic patients with multivessel coronary artery disease (MVD)...
  30. ncbi Distal embolization during directional coronary atherectomy
    Carlo Briguori
    Laboratory of Interventional Cardiology, San Raffaele Hospital, Via Olgettina 60, I 20142, Milan, Italy
    J Invasive Cardiol 15:448-50. 2003
    ..No clinical sequelae occurred in the immediate follow-up. These cases underline the problem of distal embolization during directional atherectomy, and the possibility to prevent it by using protection devices...
  31. ncbi Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty
    Carlo Briguori
    Department of Interventional Cardiology, Vita Salute University School of Medicine, San Raffaele Hospital, and EMO Centro Cuore Columbus, Milan, Italy
    Am Heart J 145:700-7. 2003
    ..Elective intra-aortic balloon pump (IABP) support may reduce acute complications occurring during percutaneous coronary interventions (PCI) in patients with severe depression of the left ventricular ejection fraction (EF < or = 30%)...
  32. doi Contrast agents and renal cell apoptosis
    Giulia Romano
    Department of Cellular and Molecular Biology and Pathology, Federico II University of Naples, Naples, Italy
    Eur Heart J 29:2569-76. 2008
    ..Contrast media (CM) induce a direct toxic effect on renal tubular cells. This toxic effect may have a role in the pathophysiology of contrast nephropathy...
  33. ncbi Contrast agent--associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy
    Prog Cardiovasc Dis 45:493-503. 2003
    ..The former may prevent the direct oxidative tissue damage, whereas the latter is a selective intrarenal vasodilator...
  34. ncbi Outcome of nonobstructive residual dissections detected by intravascular ultrasound following percutaneous coronary intervention
    Takahiro Nishida
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 89:1257-62. 2002
    ..Nonobstructive dissections can be left untreated when final IVUS reveals an area stenosis of < 60% at the site of a dissection...
  35. ncbi Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease
    Flavio Airoldi
    EMO Centro Cuore, Columbus Hospital, Milan, Italy
    Am J Cardiol 93:474-7. 2004
    ..5% in the CC group vs 32.7% in the SS group; p = 0.675). In unselected patients and lesions, carbon coating does not provide significant improvements over SS stents with the same design...
  36. ncbi Covered stent to exclude intravascular thrombus
    Francesco Liistro
    Cardiac Catheterization Laboratory, San Raffaele Hospital, Milan, Italy
    J Endovasc Ther 9:246-9. 2002
    ..To describe the utility of stent-graft implantation to avoid distal embolization from a large thrombus-containing lesion...
  37. ncbi Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy
    Eur Heart J 27:540-6. 2006
    ..However, their role after drug-eluting stent (DES) implantation is still undescribed. We assessed incidence, predictors, and outcomes of residual dissections in DES-treated lesions...
  38. ncbi Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
    Ioannis Iakovou
    Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    JAMA 293:2126-30. 2005
    ..However, delayed endothelialization associated with the implantation of drug-eluting stents may extend the risk of thrombosis beyond 30 days. Data are limited regarding the risks and the impact of this phenomenon outside clinical trials...
  39. ncbi Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions
    Ioannis Iakovou
    Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 44:967-71. 2004
    ..This observational study evaluated the clinical and angiographic outcomes of patients with aorto-ostial coronary artery disease treated with sirolimus-eluting stents (SESs) or with bare metal stents (BMSs)...
  40. doi Right coronary artery arising from pulmonary trunk: assessment with conventional coronary angiography and multislice computed tomography coronary angiography
    Carlo Tedeschi
    Cardiology Unit, San Gennaro Hospital, ASL Napoli 1, Naples, Italy bLaboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy
    J Cardiovasc Med (Hagerstown) 10:178-82. 2009
    ..The aim of this report is to emphasize the role of multislice computed tomography as an accurate noninvasive imaging tool in the evaluation of coronary artery anomalies...
  41. doi Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion
    Federico Piscione
    Department of Clinical Medicine, Cardiovascular Sciences and Immunology, Federico II University, Naples, Italy
    Catheter Cardiovasc Interv 75:715-21. 2010
    ....
  42. ncbi Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis
    Flavio Airoldi
    San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 97:1182-7. 2006
    ..The association of diffuse restenosis and diabetes mellitus is an unfavorable condition leading to a high risk of recurrence...
  43. ncbi Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis
    Flavio Airoldi
    EMO Centro Cuore, Columbus Clinic, Interventional Cardiology Unit, San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 94:1297-300. 2004
    ..The results indicate a good safety profile of the procedure and a 57% reduction in the incidence of recurrent restenosis in comparison with cutting balloon angioplasty...
  44. ncbi Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
    Flavio Airoldi
    Invasive Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circulation 116:745-54. 2007
    ..The need for prolonged aspirin and thienopyridine therapy and the risk of stent thrombosis (ST) remain as drawbacks associated with drug-eluting stents...
  45. doi Arteriovenous fistula complicating directional atherectomy of the popliteal artery
    Paolo Pagnotta
    Laboratory of Interventional Cardiology IRCCS Humanitas, Milan, Italy
    J Cardiovasc Med (Hagerstown) 10:798-800. 2009
    ..Following surgery, the patient was discharged without any deficit. Although rare, huge arteriovenous fistula may be a serious complication of peripheral directional atherectomy...
  46. pmc Carotid artery stenting in the first 100 consecutive patients: results and follow up
    G Stankovic
    Columbus Hospital, Milan, Italy
    Heart 88:381-6. 2002
    ..Carotid artery stenting is now used as an alternative to surgical endarterectomy. The availability of cerebral protection systems has expanded the area of application of this procedure...
  47. ncbi From bench to bedside: initial experience with the Primus drug-coated balloon catheter
    C Briguori
    Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Minerva Cardioangiol 60:507-15. 2012
    ..Although a variety of devices are available for clinical use, clinical outcomes have been variable and scope for significant improvement exists...
  48. ncbi Renalguard system in high-risk patients for contrast-induced acute kidney injury
    C Briguori
    Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Minerva Cardioangiol 60:291-7. 2012
    ..31; P=0.001), as well as the rate of in-hospital dialysis (4.1% versus 0.7%; P=0.056) were higher in the Control group. In conclusion, the RenalGuard therapy seems to be a promising new approach in preventing CI-AKI in high risk patients...
  49. doi Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent
    Gabriella Visconti
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy
    Catheter Cardiovasc Interv 72:873-6. 2008
    ..We describe a case of celiac trunk stenosis treated by bare metal stent complicated by recalcitrant in-stent restenosis and treated by paclitaxel-eluting stent implantation...
  50. doi Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention
    Davide Tavano
    Clinica Mediterranea, Naples, Italy
    Am J Cardiol 104:1222-8. 2009
    ....
  51. ncbi Regional thrombolytic therapy and stent implantation in an acutely occluded aortobifemoral bypass graft
    Angelo Anzuini
    Division of Cardiology, San Raffaele Hospital, Milan, Italy
    J Endovasc Ther 10:86-9. 2003
    ..To present a case highlighting the efficacy of local thrombolysis followed by stent implantation in acute occlusion of an aortobifemoral bypass graft...
  52. doi Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio, 2, I 80121 Naples, Italy
    J Am Coll Cardiol 54:2157-63. 2009
    ..It is unknown whether a single, high (80 mg) loading dose of atorvastatin may reduce the rate of periprocedural MI...
  53. ncbi First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome
    Francesco Liistro
    Catheterization Laboratories, Ospedale San Raffaele, and EMO Centro Cuore Columbus, Milan, Italy
    Circulation 105:1883-6. 2002
    ..We report the first clinical experience of 7-hexanoyltaxol (QP2)-eluting polymer stent system (QuaDS) implantation for in-stent restenosis...
  54. doi Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS)
    Enrico Romagnoli
    San Raffaele Scientific Institute, Milan, Italy
    Am Heart J 160:535-542.e1. 2010
    ..This study aimed to evaluate clinical safety and efficacy of different strategies for bifurcations treatment in a large observational real-world registry...
  55. ncbi Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina
    Carlo Briguori
    Vita Salute University School of Medicine, San Raffaele Hospital, Milan, Italy
    Am Heart J 151:674-80. 2006
    ..Intramyocardial injection of autologous bone marrow (ABM) may induce angiogenesis. We tested the safety and feasibility of catheter-based direct percutaneous intramyocardial delivery of ABM in patients with refractory angina pectoris...
  56. doi Primary percutaneous coronary intervention: different outcome for different subgroups?
    Stefano Savonitto
    Cardiology Department, Angelo De Gasperis, Niguarda Ca Granda Hospital, Milan, Italy
    J Cardiovasc Med (Hagerstown) 10:S27-34. 2009
    ....
  57. ncbi Comparison of hemodynamic adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope
    Fiore Manganelli
    Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Federico II University School of Medicine, Naples, Italy
    Am J Cardiol 89:1405-10. 2002
    ....
  58. ncbi Polytetrafluoroethylene-covered stent and coronary artery aneurysms
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita Salute University School of Medicine, San Raffaele Hospital, Milan, Italy
    Catheter Cardiovasc Interv 55:326-30. 2002
    ..Restenosis occurred in one patient (14%) who had repeat percutaneous coronary interventions. This preliminary experience suggests that PTFE-covered stent may be useful in the treatment of coronary artery aneurysms...
  59. doi Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents
    Alaide Chieffo
    Department of Cardio Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 104:1660-7. 2009
    ..The different smooth muscle cell phenotypes within the stent types might suggest different mechanisms of restenosis...
  60. doi Stent implantation in patients with severe left ventricular systolic dysfunction
    Carlo Briguori
    Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Int J Cardiol 135:376-84. 2009
    ..Patients with ischemic severe left ventricular (LV) dysfunction are at higher risk for death. We assessed the outcome following percutaneous coronary intervention (PCI) in patients with LV systolic dysfunction...
  61. doi Correlations between progression of coronary artery disease and circulating endothelial progenitor cells
    Carlo Briguori
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy
    FASEB J 24:1981-8. 2010
    ..01-1.04; P=0.001), low plasma levels of CFU-ECs (OR=3.99; 95% CI 1.54-10.37; P=0.005), and male sex (OR=3.42; 95% CI 1.15-10.22; P=0.027). Circulating levels of EPCs are significantly lower in patients with angiographic CAD progression...
  62. ncbi Elective versus provisional intraaortic balloon pumping in unprotected left main stenting
    Carlo Briguori
    Department of Interventional Cardiology, Vita Salute University School of Medicine, San Raffaele Hospital, Milan, Italy brigouri carlo hsr it
    Am Heart J 152:565-72. 2006
    ..Elective intraaortic balloon pump (IABP) may reduce acute complications during unprotected left main (ULM) stenting. However, few data exist on criteria for elective IABP support during ULM stenting...
  63. ncbi A randomized comparison of direct stenting versus stenting with predilatation in native coronary artery disease: results from the multicentric Crosscut study
    Flavio Airoldi
    Interventional Cardiology Unit, San Raffaele Hospital, Via Olgettina, 60 20132 Milan, Italy
    J Invasive Cardiol 15:1-5. 2003
    ..Clinical and angiographic results at 6 months are comparable to those obtained after a conventional predilatation-stenting strategy...
  64. ncbi Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheter
    Flavio Airoldi
    EMO Centro Cuore, Columbus Clinic, Via Buonarroti 48 20145 Milan, Italy
    Am J Cardiol 92:725-8. 2003
    ..6% of patients. The secondary end point regarding the incidence of angiographic restenosis at 6 months showed a high restenosis rate (65%)...
  65. ncbi Impact of microvascular complications on outcome after coronary stent implantations in patients with diabetes
    Carlo Briguori
    J Am Coll Cardiol 45:464-6. 2005
  66. doi Multimodality prevention of contrast-induced acute kidney injury
    Carlo Briguori
    Am J Kidney Dis 51:1068; author reply 1068-9. 2008
  67. ncbi Endovascular stenting for stenoses in surgically reconstructed brachiocephalic bypass grafts: immediate and midterm outcomes
    Angelo Anzuini
    University of Texas Medical Branch, Galveston, USA
    J Endovasc Ther 11:263-8. 2004
    ..To report the use of endovascular stenting for treatment of patients with symptomatic obstruction of brachiocephalic surgical reconstructions...
  68. ncbi [Clinical studies of cardiac cell therapy in Italy]
    Giulio Pompilio
    Dipartimento di Chirurgia Cardiovascolare, Centro Cardiologico Monzino IRCCS e Università degli Studi, Milano
    G Ital Cardiol (Rome) 8:586-91. 2007
    ..This article is aimed to point out the challenges and debated issues in the conduction of clinical trials, focusing on the Italian clinical and regulatory existing situation...